While major pharmacy benefit management reform was stripped out of the Big Beautiful Bill, a bipartisan group of ...

A bill introduced by Rep. Buddy Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.

Although the Legislature has adjourned the 2025 session, senators are already hard at work crafting bills for January, ...

UnitedHealth's management has already signaled an improving outlook for the second half of 2025. Click here to read an ...

The Cigna Group's fundamentals are solid, but the stock is fairly valued versus peers, not a bargain. Click here to find out ...

Freshmen legislators wrapped up their first legislative session in the Oklahoma House and Oklahoma Senate for the 60th Legislature this past June. Sen. Spencer Kern, Rep. Stacy Jo Adams and Sen.

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $484.4, a high estimate of $522.00, and a low estimate of $434.00. A negative shift in sentiment ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Scripta Insights, the doctor-driven, AI-powered Rx Navigation™ company, announced today the launch of its Fiduciary ...

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...